Monthly Archives: March 2018

//March
27 03, 2018

The Impact of Remote Monitoring on CRAs | Central Monitoring Summit

2018-03-27T21:24:16+00:00

While presenting at Central Monitoring Summit 2018, Elizabeth Robinson of Horizon Pharma shared a strong data point: In the coming years, Clinical Research Associates (CRAs) will experience more change to their jobs than any other research profession (2017 Applied Clinical Trials survey). This statement spurred a conversation amongst the room about what will change [...]

The Impact of Remote Monitoring on CRAs | Central Monitoring Summit2018-03-27T21:24:16+00:00
19 03, 2018

[Infographic] Launching eSignatures in Clinical Trials while Avoiding Part 11 Risks

2018-06-18T15:25:39+00:00

Electronic signatures, eSignatures, are continuing to gain momentum in the clinical trial landscape. The immediate benefits of eSignatures are clear -  your team can eliminate the printing of most regulatory documents, chasing signers, and scanning and faxing files.However, recent advances in purpose-built solutions employ eSignatures for far more than these basic benefits. Solutions in eRegulatory [...]

[Infographic] Launching eSignatures in Clinical Trials while Avoiding Part 11 Risks2018-06-18T15:25:39+00:00
12 03, 2018

Cancer Research Is Accelerating, but We Can Do Better

2018-03-12T10:48:40+00:00

The rate of cancer death has been decreasing, and people are living longer with cancer than ever before. Approximately 64% of US patients diagnosed with cancer in 2005 have lived 10 years or more beyond diagnosis, up from 35% for those diagnosed in 1975. — American Society of Clinical Oncology Cancer Advances Report, 2018. [...]

Cancer Research Is Accelerating, but We Can Do Better2018-03-12T10:48:40+00:00